CeriBell, Inc (CBLL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CeriBell, Inc (CBLL) has a cash flow conversion efficiency ratio of -0.137x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-19.30 Million) by net assets ($140.81 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CBLL net asset quality index to measure how much of total assets are equity-financed.
CeriBell, Inc - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how CeriBell, Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore CBLL cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
CeriBell, Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CeriBell, Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hefei Fengle Seed Co Ltd
SHE:000713
|
0.122x |
|
Pan-International Industrial Corp
TW:2328
|
0.044x |
|
Zhengzhou Coal Industry & Electric Power Co Ltd
SHG:600121
|
-0.007x |
|
Cikarang Listrindo Tbk PT
JK:POWR
|
0.074x |
|
Siteminder Ltd
AU:SDR
|
0.292x |
|
2G Energy AG
XETRA:2GB
|
-0.175x |
|
Shenzhen WOTE Advanced Materials Co Ltd
SHE:002886
|
0.017x |
|
Inti Bangun Sejahtera Tbk
JK:IBST
|
0.171x |
Annual Cash Flow Conversion Efficiency for CeriBell, Inc (2022–2025)
The table below shows the annual cash flow conversion efficiency of CeriBell, Inc from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see CBLL market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $155.34 Million | $-40.81 Million | -0.263x | -43.31% |
| 2024-12-31 | $191.16 Million | $-35.04 Million | -0.183x | -170.57% |
| 2023-12-31 | $-112.25 Million | $-29.16 Million | 0.260x | -29.87% |
| 2022-12-31 | $-86.40 Million | $-32.00 Million | 0.370x | -- |
About CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more